ulipristal acetate

GPTKB entity

Statements (48)
Predicate Object
gptkbp:instanceOf gptkb:drug
selective progesterone receptor modulator
gptkbp:approvalYear 2009
2010
gptkbp:approvedBy gptkb:European_Union
gptkb:United_States
gptkb:European_Medicines_Agency
gptkbp:ATCCode G03AD02
gptkbp:brand gptkb:Ella
gptkb:Esmya
gptkbp:CASNumber 126784-99-4
gptkbp:contraindication pregnancy
severe liver disease
gptkbp:developedBy HRA Pharma
gptkbp:discoveredBy HRA Pharma
gptkbp:drugClass oral contraceptive
hormonal medication
antiprogestogen
gptkbp:eliminationHalfLife 32 hours
gptkbp:excretion urine
feces
gptkbp:hasMolecularFormula C30H37NO4
https://www.w3.org/2000/01/rdf-schema#label ulipristal acetate
gptkbp:legalStatus prescription only
gptkbp:mechanismOfAction progesterone receptor antagonist
gptkbp:metabolism liver
gptkbp:pregnancyCategory D
X
contraindicated
gptkbp:pregnancyCategoryEU contraindicated
gptkbp:prescriptionStatus prescription only
gptkbp:PubChem_CID gptkb:CHEMBL1201197
135565087
24609941
gptkbp:routeOfAdministration oral
gptkbp:sideEffect nausea
abdominal pain
fatigue
headache
dysmenorrhea
gptkbp:synonym CDB-2914
VA2914
17α-acetoxy-11β-(4-N,N-dimethylaminophenyl)-19-norpregna-4,9-diene-3,20-dione
gptkbp:UNII Y5L0U73M7A
gptkbp:usedFor oral contraceptive
treatment of uterine fibroids
gptkbp:bfsParent gptkb:EC_stack
gptkbp:bfsLayer 7